Total planned funding: $123,105,583
Allocations
Countries/Regions
India | $123,105,583 |
Organizational Types
Unknown | $53,788,036 |
NGO | $33,366,500 |
Own Agency | $19,325,844 |
University | $9,791,895 |
Multi-lateral Agency | $2,206,808 |
FBO | $2,000,000 |
Private Contractor | $1,659,000 |
Other USG Agency | $627,300 |
Host Country Government Agency | $340,200 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $44,098,934 |
Prevention | $31,796,337 |
Care | $17,464,158 |
Management and Operations | $14,122,400 |
Treatment | $5,809,252 |
Testing | $5,386,710 |
Budget Codes
OHSS: Health Systems Strengthening | $24,645,805 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,606,762 |
HVMS: Management and Operations | $14,122,400 |
HVSI: Strategic Information | $13,138,356 |
HBHC: Care: Adult Care and Support | $10,740,258 |
HLAB: Laboratory Infrastructure | $6,314,773 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,921,863 |
HVCT: Testing: HIV Testing and Counseling | $5,386,710 |
HTXS: Treatment: Adult Treatment | $5,284,711 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,072,872 |
HVTB: Care: TB/HIV | $3,160,280 |
HKID: Care: Orphans and Vulnerable Children | $3,139,601 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,315,004 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
PDTX: Treatment: Pediatric Treatment | $501,064 |
PDCS: Care: Pediatric Care and Support | $424,019 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$53,163,547
Countries/Regions
FHI 360:
$10,999,000
Countries/Regions
USG Aggregated Agencies:
$9,634,639
Countries/Regions
Voluntary Health Services:
$6,650,000
Countries/Regions